The London-based platform, which already covers 1.5 million eligible lives in healthcare and enterprise deployments, is using the Series A to accelerate entry into the US market and deepen its clinical infrastructure, with a new CEO who sold his last company to Adobe.
JAAQ, the London-based digital health engagement platform, has raised $17 million in a Series A round. The investment comes from Meridian Health Ventures, Fuel Ventures, Bolt Angels and Guinness Ventures, with capital allocated to expand business partnerships, deepen clinical infrastructure and expand into the United States. Dr. Pooja Sikka, a partner at Meridian Health Ventures, joined the company’s board of directors as part of the deal.
The company was founded in 2021 with a direct-to-consumer model based on video-based mental health content. It has since pivoted toward an enterprise and healthcare focus, embedding that library of content — now more than 10,000 clinically reviewed videos — within the digital products of insurers, employers and healthcare organizations rather than distributing it to individual users.
The logic is structural: Instead of asking people to find a mental health platform, JAAQ places its content within the apps and services they are already using. It currently covers more than 1.5 million eligible lives through active enterprise deployments.
Alex Packham has joined as CEO to lead the business into its next phase. Packham is best known for ContentCal, a social media management SaaS platform that he created and sold to Adobe in December 2021, after which he spent three years leading the integration of the product within Adobe before leaving.
The platform’s commercial proposition has two layers. Organizations can license content from the JAAQ library and integrate it into their own products, or they can license a custom hosted JAAQ experience.
The company is also building an infrastructure it describes as a “clinical engagement layer” for native AI products, designed to allow any digital product or team to embed governed mental health content into users’ journeys without building the clinical governance apparatus themselves.
The argument for businesses is that this addresses two problems simultaneously: the mental health access gap and low engagement with wellness benefits that organizations invest in but which employees rarely use.
The clinical governance framework is critical for JAAQ to differentiate itself from generic AI wellness tools. The platform’s content is produced within a defined clinical and creative framework, rather than generated on demand, and Johri’s appointment is intended to signal that the product is being built with clinical credibility built in rather than bolted on.
Meridian Health Ventures, which focuses specifically on UK healthtech with access to the US market, fits that positioning perfectly: the company runs the first NHS-anchored venture fund and has a dedicated Mental Health Innovations Fund.
The expansion of the United States is the strategic priority that the financing aims to unlock. The UK market has provided validation, with the company’s website referencing case studies including a UK bank that saved £896,000 in employee productivity and wellbeing improvements, and an insurer that diverted the equivalent of twelve full-time customer service roles through content served by JAAQ.
The next test is translating that model to the U.S. employer and health insurer market, where mental health benefits are increasingly a priority at the board level but engagement remains a persistent problem.
